Calculation of NNTs in RCTs with time-to-event outcomes: A literature review

BMC Medical Research Methodology

Volumn 9, Issue 1, 2009, Pages

  Hildebrandt, Mandy ^a,b   Vervölgyi, Elke ^a   Bender, Ralf ^a,c  

^a INSTITUTE FOR QUALITY AND EFFICIENCY IN HEALTH CARE IQWIG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; DATA ANALYSIS; HUMAN; KAPLAN MEIER METHOD; NUMBER NEEDED TO TREAT; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; CONFIDENCE INTERVAL; METHODOLOGY; REVIEW; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICS;

CONFIDENCE INTERVALS; DATA INTERPRETATION, STATISTICAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SAMPLE SIZE;

EID: 64249137634     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-9-21     Document Type: Article

References (27)

1. An assessment of clinically useful measures of the consequences of treatment. A Laupacis DL Sackett RS Roberts, N Engl J Med 1988 318 1728 1733 3374545
2. The number needed to treat: A clinically useful measure of treatment effect. RJ Cook DL Sackett, BMJ 1995 310 452 454 7873954
3. Choice of effect measure for epidemiological data. SD Walter, J Clin Epidemiol 2000 53 931 939 10.1016/S0895-4356(00)00210-9 11004419
4. Number needed to treat: Properties and problems. JL Hutton, J R Stat Soc A 2000 163 403 415
5. Comments on the paper by Hutton. DG Altman JJ Deeks, J R Stat Soc A 2000 163 415 416
6. Comments on the paper by Hutton. E Lesaffre G Pledger, J R Stat Soc A 2000 163 417
7. Number needed to treat: Easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. IS Kristiansen D Gyrd-Hansen J Nexøe JB Nielsen, J Clin Epidemiol 2002 55 888 892 10.1016/S0895- 4356(02)00432-8 12393076
8. The number needed to treat: A useful clinical measure or a case of the Emperor's new clothes? AP Grieve, Pharmaceut Stat 2003 2 87 102 10.1002/pst.33
9. Decisions on drug therapies by numbers needed to treat: A randomized trial. PA Halvorsen IS Kristiansen, Arch Intern Med 2005 165 1140 1146 10.1001/archinte.165.10.1140 15911727
10. Influence of number needed to treat, costs and outcome on preferences for a preventive drug. J Nexøe IS Kristiansen D Gyrd-Hansen JB Nielsen, Fam Pract 2005 22 126 131 10.1093/fampra/cmh706 15640298
11. Different ways to describe the benefits of risk-reducing treatments: A randomized trial. PA Halvorsen R Selmer IS Kristiansen, Ann Intern Med 2007 146 848 856 17577004
12. Number needed to treat (NNT). R Bender, Encyclopedia of Biostatistics Chichester: Wiley, Armitage P, Colton T, 2005 3752 3761
13. The revised CONSORT statement for reporting randomized trials: Explanation and elaboration. DG Altman KF Schulz D Moher M Egger F Davidoff DR Elbourne PC Gøtzsche T Lang for the CONSORT Group, Ann Intern Med 2001 134 663 694 11304107
14. Calculating the number needed to treat where the outcome is time to an event. DG Altman PK Andersen, BMJ 1999 319 1492 1495 10582940
15. Implications of trial results: The potentially misleading notations of number needed to treat and average duration life gained. J Lubsen A Hoes D Grobbee, Lancet 2000 356 1757 1759 10.1016/S0140-6736(00)03215-3 11095272
16. Annualized was found better than absolute risk reduction in the calculation of number needed to treat in chronic conditions. TJ Mayne E Whalen A Vu, J Clin Epidemiol 2006 59 217 223 10.1016/j.jclinepi.2005.07.006 16488351
17. Parameter estimation for the linear hazard rate distribution based on records and inter-record times. C-T Lin SJS Wu N Balakrishnan, Commun Stat A 2003 32 729 748
18. Confidence intervals for an exposure adjusted incidence rate difference with applications to clinical trials. GF Liu J Wang K Liu DB Snavely, Stat Med 2006 25 1275 1286 10.1002/sim.2335 16138360
19. Reporting number needed to treat and absolute risk reduction in randomized controlled trials. J Nuovo J Melnikow D Chang, JAMA 2002 287 2813 2814 10.1001/jama.287.21.2813 12038920
20. NNT for studies with long-term follow-up (Letter). ML de Lemos, CMAJ 2005 172 613 author reply 613615 15738471
21. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomized trials. D Moher KF Schulz DG Altman for the CONSORT Group, Ann Intern Med 2001 134 657 662 11304106
22. Confidence intervals for the number needed to treat. DG Altman, BMJ 1998 317 1309 1312 9804726
23. A note on the number needed to treat. E Lesaffre G Pledger, Control Clin Trials 1999 20 439 447 10.1016/S0197-2456(99)00018-5 10503803
24. Calculating confidence intervals for the number needed to treat. R Bender, Control Clin Trials 2001 22 102 110 10.1016/S0197-2456(00)00134-3 11306148
25. Missing the point (estimate)? Confidence intervals for the number needed to treat. NJ Barrowman, CMAJ 2002 166 1676 1677 12126323
26. Calculating confidence intervals for impact numbers. M Hildebrandt R Bender U Gehrmann M Blettner, BMC Med Res Methodol 2006 6 32 16836748 10.1186/1471-2288-6-32
27. Estimating adjusted NNT measures in logistic regression analysis. R Bender O Kuss M Hildebrandt U Gehrmann, Stat Med 2007 26 5586 5595 10.1002/sim.3061 17879268